Skip to content

Patients' Perspectives on Metabolic Dysfunction-associated Steatohepatitis: a Qualitative Study

Perspectives on the Multidisciplinary Approach to Metabolic Dysfunction-associated Steatohepatitis: a Qualitative Study With Patients From the MASH-Cardiovascular Programme at Hospital de Sant Pau i la Santa Creu, Barcelona

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07188220
Enrollment
25
Registered
2025-09-23
Start date
2025-06-03
Completion date
2028-01-20
Last updated
2025-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Dysfunction Associated Steatohepatitis (MASH)

Keywords

Qualitative, MASH, MASLD, Perceptions, Semi-structured interviews

Brief summary

The aim of this qualitative study is to explore and identify the expectations, perceptions, attitudes, needs, and knowledge related to the management of metabolic dysfunction-associated steatohepatitis (MASH) in patients diagnosed with this condition, before and after their participation in the MASH-Cardiovascular Programme at Hospital de la Santa Creu i Sant Pau, Barcelona. The main research question is: What expectations, attitudes, needs, and perceptions do patients with MASH participating in the MASH-Cardiovascular Programme exhibit before and after the intervention? Participants will undergo two semi-structured interviews: one prior to, and one following, their involvement in the MASH-Cardiovascular Programme at Hospital de Sant Pau i la Santa Creu, Barcelona.

Interventions

None listed

Sponsors

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years

Inclusion criteria

* Patients who voluntarily agree to participate in the MASH-Cardiovascular Programme. * Patients followed in the outpatient hepatology/gastroenterology clinic at Hospital de Sant Pau with a diagnosis of MASH and fibrosis stage F2-F4. * Patients aged between 18 and 75 years. * Patients with a BMI ≥ 27 kg/m². * Patients who consent to participate in the study-specific interviews.

Exclusion criteria

* Patients who do not agree to participate in the study-specific interviews. * Patients meeting

Design outcomes

Primary

MeasureTime frameDescription
PerceptionsAt baseline (within two weeks before starting the programme) and at one-year follow-up (within two weeks before and after completing the programme)Perceptions explored through semi-structured interviews
Attitudes and expectativesAt baseline (within two weeks before starting the programme) and at one-year follow-up (within two weeks before and after completing the programme)Attitudes and expectatives explored through semi-structured interviews
MASH-related knowledgeAt baseline (within two weeks before starting the programme) and at one-year follow-up (within two weeks before and after completing the programme)MASH-related knowledge explored through semi-structured interviews
Unmet needsAt baseline (within two weeks before starting the programme) and at one-year follow-up (within two weeks before and after completing the programme)Unmet needs explored through semi-structured interviews

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026